Literature DB >> 20722053

Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis.

Magaly Zappa1, Carmen Stefanescu, Dominique Cazals-Hatem, Frédéric Bretagnol, Lydia Deschamps, Alain Attar, Béatrice Larroque, Xavier Tréton, Yves Panis, Valérie Vilgrain, Yoram Bouhnik.   

Abstract

BACKGROUND: The aim was to evaluate the value of magnetic resonance imaging (MRI) findings in Crohn's disease (CD) in correlation with pathological inflammatory score using surgical pathology analysis as a reference method.
METHODS: CD patients who were to undergo bowel resection surgery underwent MR enterography before surgery. The CD pathological inflammatory score of the surgical specimens was classified into three grades: mild or nonactive CD, moderately active CD, and severely active CD; fibrosis was also classified into three grades: mild, moderate, and severe. Mural and extramural MRI findings were correlated with pathological inflammatory and fibrosis grades.
RESULTS: Fifty-three consecutive patients were included retrospectively. The mean delay between MRI and surgery was 24 days (range 1-90, median 14). The CD pathological inflammatory score was graded as follows: grade 0 (11 patients, 21%), grade 1 (15 patients, 28%), and grade 2 (27 patients, 51%). MRI findings significantly associated with pathological inflammatory grading were wall thickness (P < 0.0001), degree of wall enhancement on delayed phase (P < 0.0001), pattern of enhancement on both parenchymatous (P = 0.02), and delayed phase, (P = 0.008), T2 relative hypersignal wall (P < 0.0001), blurred wall enhancement (P = 0.018), comb sign (P = 0.004), fistula (P < 0.0001), and abscess (P = 0.049). The inflammation score correlated with the fibrosis score (r = 0.63, P = 0.0001).
CONCLUSIONS: Our study identified MRI findings significantly associated with surgical pathological inflammation. These lesions are considered potentially reversible and may be efficiently treated medically. We also showed that fibrosis was closely and positively related to inflammation.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722053     DOI: 10.1002/ibd.21414

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  57 in total

Review 1.  MRI in Crohn's disease--current and future clinical applications.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Alberto Malesci; Luca Balzarini; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

2.  Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.

Authors:  Jesica C Makanyanga; Doug Pendsé; Nikolaos Dikaios; Stuart Bloom; Sara McCartney; Emma Helbren; Elaine Atkins; Terry Cuthbertson; Shonit Punwani; Alastair Forbes; Steve Halligan; Stuart A Taylor
Journal:  Eur Radiol       Date:  2013-09-12       Impact factor: 5.315

3.  How I do it: Side-to-side isoperistaltic strictureplasty for extensive Crohn's disease.

Authors:  Léon Maggiori; Fabrizio Michelassi
Journal:  J Gastrointest Surg       Date:  2012-04-27       Impact factor: 3.452

4.  Comparative study of intestinal tuberculosis and primary small intestinal lymphoma.

Authors:  Qing-Qiang Zhu; Wen-Rong Zhu; Jing-Tao Wu; Wen-Xin Chen; Shou-An Wang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 5.  Newer CT applications and their alternatives: what is appropriate in children?

Authors:  R Paul Guillerman
Journal:  Pediatr Radiol       Date:  2011-08-17

6.  Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.

Authors:  Peter D R Higgins; Joel G Fletcher
Journal:  Am J Gastroenterol       Date:  2015-03       Impact factor: 10.864

7.  Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.

Authors:  Cécile Campos; Antoine Perrey; Céline Lambert; Bruno Pereira; Marion Goutte; Anne Dubois; Felix Goutorbe; Michel Dapoigny; Gilles Bommelaer; Constance Hordonneau; Anthony Buisson
Journal:  Dig Dis Sci       Date:  2017-04-11       Impact factor: 3.199

8.  Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging.

Authors:  M Barat; C Hoeffel; M Bouquot; A S Jannot; R Dautry; M Boudiaf; K Pautrat; R Kaci; M Camus; C Eveno; M Pocard; P Soyer; A Dohan
Journal:  Eur Radiol       Date:  2018-10-09       Impact factor: 5.315

9.  Outcomes of computed tomography and magnetic resonance enterography in clinical practice of inflammatory bowel disease.

Authors:  Niraj S Patel; Suresh Pola; Ramya Muralimohan; G Y Zou; Cynthia Santillan; Derek Patel; Barrett G Levesque; William J Sandborn
Journal:  Dig Dis Sci       Date:  2013-12-10       Impact factor: 3.199

10.  PET/MR Versus PET/CT Imaging: Impact on the Clinical Management of Small-Bowel Crohn's Disease.

Authors:  Gianluca Pellino; Emanuele Nicolai; Onofrio A Catalano; Severo Campione; Francesco P D'Armiento; Marco Salvatore; Alberto Cuocolo; Francesco Selvaggi
Journal:  J Crohns Colitis       Date:  2015-11-15       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.